Geoffrey Hird PhD, BS

Geoff Hird has over 15 years of pharmaceutical industry experience in product development of topical, parenteral, pulmonary and oral formulations of small and large molecules. He is currently focused on integrating Liquidia’s PRINT® technology into topical formulations being developed with partners. Prior to joining Liquidia, Geoff led global CMC teams developing topical drugs at GSK and Eisai. In addition to working in industry, Geoff enjoys teaching as an Adjunct Professor at the UNC Chapel Hill Eschelmen School of Pharmacy and reviewing grants for the American Cancer Society as a member of the Cancer Drug Discovery Study Section. Geoff received his Ph.D. in Chemistry from Duke University where he developed a novel liposomal drug delivery system